ID   HUTH_HUMAN              Reviewed;         657 AA.
AC   P42357; B4DQC1; B4E0V8; F5GXF2; F5H1U5; Q4VB92; Q4VB93;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   12-APR-2017, entry version 158.
DE   RecName: Full=Histidine ammonia-lyase;
DE            Short=Histidase;
DE            EC=4.3.1.3;
GN   Name=HAL; Synonyms=HIS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7916645; DOI=10.1016/0167-4781(93)90157-9;
RA   Suchi M., Harada N., Wada Y., Takagi Y.;
RT   "Molecular cloning of a cDNA encoding human histidase.";
RL   Biochim. Biophys. Acta 1216:293-295(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-439.
RX   PubMed=8530107; DOI=10.1006/geno.1995.1219;
RA   Suchi M., Sano H., Mizuno H., Wada Y.;
RT   "Molecular cloning and structural characterization of the human
RT   histidase gene (HAL).";
RL   Genomics 29:98-104(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ILE-439.
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-439.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-439.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANTS HISTID THR-206; LEU-208; LEU-259 AND PRO-322.
RX   PubMed=15806399; DOI=10.1007/s00439-004-1232-5;
RA   Kawai Y., Moriyama A., Asai K., Coleman-Campbell C.M., Sumi S.,
RA   Morishita H., Suchi M.;
RT   "Molecular characterization of histidinemia: identification of four
RT   missense mutations in the histidase gene.";
RL   Hum. Genet. 116:340-346(2005).
CC   -!- CATALYTIC ACTIVITY: L-histidine = urocanate + NH(3).
CC       {ECO:0000255|PROSITE-ProRule:PRU10122}.
CC   -!- PATHWAY: Amino-acid degradation; L-histidine degradation into L-
CC       glutamate; N-formimidoyl-L-glutamate from L-histidine: step 1/3.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P42357-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42357-2; Sequence=VSP_044704;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P42357-3; Sequence=VSP_046003;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Contains an active site 4-methylidene-imidazol-5-one (MIO),
CC       which is formed autocatalytically by cyclization and dehydration
CC       of residues Ala-Ser-Gly. {ECO:0000250}.
CC   -!- DISEASE: Histidinemia (HISTID) [MIM:235800]: Autosomal recessive
CC       disease characterized by increased histidine and histamine as well
CC       as decreased urocanic acid in body fluids.
CC       {ECO:0000269|PubMed:15806399}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PAL/histidase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16626; BAA04047.1; -; mRNA.
DR   EMBL; AB042217; BAB61863.1; -; Genomic_DNA.
DR   EMBL; AK298736; BAG60883.1; -; mRNA.
DR   EMBL; AK303544; BAG64570.1; -; mRNA.
DR   EMBL; AC007298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC126174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97556.1; -; Genomic_DNA.
DR   EMBL; BC096097; AAH96097.1; -; mRNA.
DR   EMBL; BC096098; AAH96098.1; -; mRNA.
DR   EMBL; BC096099; AAH96099.1; -; mRNA.
DR   CCDS; CCDS58264.1; -. [P42357-3]
DR   CCDS; CCDS58265.1; -. [P42357-2]
DR   CCDS; CCDS9058.1; -. [P42357-1]
DR   PIR; S43415; S43415.
DR   RefSeq; NP_001245262.1; NM_001258333.1. [P42357-3]
DR   RefSeq; NP_001245263.1; NM_001258334.1. [P42357-2]
DR   RefSeq; NP_002099.1; NM_002108.3. [P42357-1]
DR   UniGene; Hs.190783; -.
DR   UniGene; Hs.742210; -.
DR   ProteinModelPortal; P42357; -.
DR   SMR; P42357; -.
DR   BioGrid; 109284; 34.
DR   IntAct; P42357; 1.
DR   STRING; 9606.ENSP00000261208; -.
DR   ChEMBL; CHEMBL4003; -.
DR   DrugBank; DB00117; L-Histidine.
DR   iPTMnet; P42357; -.
DR   PhosphoSitePlus; P42357; -.
DR   BioMuta; HAL; -.
DR   DMDM; 1170423; -.
DR   EPD; P42357; -.
DR   MaxQB; P42357; -.
DR   PaxDb; P42357; -.
DR   PeptideAtlas; P42357; -.
DR   PRIDE; P42357; -.
DR   Ensembl; ENST00000261208; ENSP00000261208; ENSG00000084110. [P42357-1]
DR   Ensembl; ENST00000538703; ENSP00000440861; ENSG00000084110. [P42357-2]
DR   Ensembl; ENST00000541929; ENSP00000446364; ENSG00000084110. [P42357-3]
DR   GeneID; 3034; -.
DR   KEGG; hsa:3034; -.
DR   UCSC; uc001tem.2; human. [P42357-1]
DR   CTD; 3034; -.
DR   DisGeNET; 3034; -.
DR   GeneCards; HAL; -.
DR   HGNC; HGNC:4806; HAL.
DR   HPA; HPA038547; -.
DR   HPA; HPA038548; -.
DR   MalaCards; HAL; -.
DR   MIM; 235800; phenotype.
DR   MIM; 609457; gene.
DR   neXtProt; NX_P42357; -.
DR   OpenTargets; ENSG00000084110; -.
DR   Orphanet; 2157; Histidinemia.
DR   PharmGKB; PA29181; -.
DR   eggNOG; KOG0222; Eukaryota.
DR   eggNOG; COG2986; LUCA.
DR   GeneTree; ENSGT00390000009047; -.
DR   HOGENOM; HOG000237619; -.
DR   HOVERGEN; HBG004509; -.
DR   InParanoid; P42357; -.
DR   KO; K01745; -.
DR   OMA; CFLVRRC; -.
DR   OrthoDB; EOG091G036O; -.
DR   PhylomeDB; P42357; -.
DR   TreeFam; TF313824; -.
DR   BioCyc; MetaCyc:HS01466-MONOMER; -.
DR   Reactome; R-HSA-70921; Histidine catabolism.
DR   UniPathway; UPA00379; UER00549.
DR   GeneWiki; Histidine_ammonia-lyase; -.
DR   GenomeRNAi; 3034; -.
DR   PRO; PR:P42357; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000084110; -.
DR   CleanEx; HS_HAL; -.
DR   ExpressionAtlas; P42357; baseline and differential.
DR   Genevisible; P42357; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004397; F:histidine ammonia-lyase activity; EXP:Reactome.
DR   GO; GO:0006548; P:histidine catabolic process; TAS:Reactome.
DR   GO; GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway.
DR   CDD; cd00332; PAL-HAL; 1.
DR   Gene3D; 1.10.275.10; -; 1.
DR   InterPro; IPR001106; Aromatic_Lyase.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR005921; HutH.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   InterPro; IPR022313; Phe/His_NH3-lyase_AS.
DR   Pfam; PF00221; Lyase_aromatic; 1.
DR   SUPFAM; SSF48557; SSF48557; 1.
DR   TIGRFAMs; TIGR01225; hutH; 1.
DR   PROSITE; PS00488; PAL_HISTIDASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Histidine metabolism; Lyase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    657       Histidine ammonia-lyase.
FT                                /FTId=PRO_0000161058.
FT   MOD_RES     254    254       2,3-didehydroalanine (Ser).
FT                                {ECO:0000255|PROSITE-ProRule:PRU10122}.
FT   MOD_RES     396    396       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P35492}.
FT   MOD_RES     635    635       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P21213}.
FT   MOD_RES     637    637       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P35492}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35492}.
FT   CROSSLNK    253    255       5-imidazolinone (Ala-Gly). {ECO:0000250}.
FT   VAR_SEQ       1    208       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046003.
FT   VAR_SEQ     589    657       PWIKDRFMAPDIEAAHRLLLEQKVWEVAAPYIEKYRMEHIP
FT                                ESRPLSPTAFSLQFLHKKSTKIPESEDL -> FGK (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044704.
FT   VARIANT     206    206       R -> T (in HISTID; dbSNP:rs121434327).
FT                                {ECO:0000269|PubMed:15806399}.
FT                                /FTId=VAR_022915.
FT   VARIANT     208    208       R -> L (in HISTID; dbSNP:rs121434328).
FT                                {ECO:0000269|PubMed:15806399}.
FT                                /FTId=VAR_022916.
FT   VARIANT     259    259       P -> L (in HISTID; dbSNP:rs121434329).
FT                                {ECO:0000269|PubMed:15806399}.
FT                                /FTId=VAR_022917.
FT   VARIANT     322    322       R -> P (in HISTID; dbSNP:rs121434330).
FT                                {ECO:0000269|PubMed:15806399}.
FT                                /FTId=VAR_022918.
FT   VARIANT     439    439       V -> I (in dbSNP:rs7297245).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8530107,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_006042.
FT   CONFLICT    549    549       V -> M (in Ref. 3; BAG64570).
FT                                {ECO:0000305}.
SQ   SEQUENCE   657 AA;  72698 MW;  6B9FF97C066FB8F1 CRC64;
     MPRYTVHVRG EWLAVPCQDA QLTVGWLGRE AVRRYIKNKP DNGGFTSVDD AHFLVRRCKG
     LGLLDNEDRL EVALENNEFV EVVIEGDAMS PDFIPSQPEG VYLYSKYREP EKYIELDGDR
     LTTEDLVNLG KGRYKIKLTP TAEKRVQKSR EVIDSIIKEK TVVYGITTGF GKFARTVIPI
     NKLQELQVNL VRSHSSGVGK PLSPERCRML LALRINVLAK GYSGISLETL KQVIEMFNAS
     CLPYVPEKGT VGASGDLAPL SHLALGLVGE GKMWSPKSGW ADAKYVLEAH GLKPVILKPK
     EGLALINGTQ MITSLGCEAV ERASAIARQA DIVAALTLEV LKGTTKAFDT DIHALRPHRG
     QIEVAFRFRS LLDSDHHPSE IAESHRFCDR VQDAYTLRCC PQVHGVVNDT IAFVKNIITT
     ELNSATDNPM VFANRGETVS GGNFHGEYPA KALDYLAIGI HELAAISERR IERLCNPSLS
     ELPAFLVAEG GLNSGFMIAH CTAAALVSEN KALCHPSSVD SLSTSAATED HVSMGGWAAR
     KALRVIEHVE QVLAIELLAA CQGIEFLRPL KTTTPLEKVY DLVRSVVRPW IKDRFMAPDI
     EAAHRLLLEQ KVWEVAAPYI EKYRMEHIPE SRPLSPTAFS LQFLHKKSTK IPESEDL
//
